LINC02308
gene geneOn this page
Summary
LINC02308 (long intergenic non-protein coding RNA 2308, HGNC:53227) is a long non-coding RNA gene on chromosome 14q31.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53227 |
| Approved symbol | LINC02308 |
| Name | long intergenic non-protein coding RNA 2308 |
| Location | 14q31.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000258675 |
| Ensembl biotype | lncRNA |
| Entrez | 100506700 |
| RNAcentral | URS000075AC0D — lncRNA, 656 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 lncRNA
ENST00000555001, ENST00000656095, ENST00000657354, ENST00000668972, ENST00000769791, ENST00000769792
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000555001 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002444713 | 81441987 | 81442196 |
| ENSE00002492298 | 81442285 | 81442442 |
| ENSE00004131228 | 81449889 | 81450377 |
Expression profiles
Bgee: expression breadth ubiquitous, 114 present calls, max score 83.58.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0634 / max 20.1003, expressed in 22 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144330 | 0.0421 | 17 |
| 144329 | 0.0213 | 9 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.58 | gold quality |
| cerebellar vermis | UBERON:0004720 | 77.24 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 76.61 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 74.50 | gold quality |
| muscle of leg | UBERON:0001383 | 72.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 72.08 | gold quality |
| gastrocnemius | UBERON:0001388 | 71.58 | gold quality |
| muscle tissue | UBERON:0002385 | 69.74 | gold quality |
| ventricular zone | UBERON:0003053 | 68.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 65.68 | gold quality |
| bone marrow | UBERON:0002371 | 63.48 | silver quality |
| thymus | UBERON:0002370 | 62.08 | silver quality |
| calcaneal tendon | UBERON:0003701 | 59.87 | gold quality |
| left ovary | UBERON:0002119 | 59.58 | gold quality |
| ovary | UBERON:0000992 | 59.28 | gold quality |
| lymph node | UBERON:0000029 | 58.04 | gold quality |
| gall bladder | UBERON:0002110 | 56.14 | gold quality |
| ectocervix | UBERON:0012249 | 55.68 | gold quality |
| liver | UBERON:0002107 | 54.93 | silver quality |
| apex of heart | UBERON:0002098 | 54.86 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.22 | gold quality |
| right ovary | UBERON:0002118 | 54.07 | gold quality |
| spleen | UBERON:0002106 | 54.04 | gold quality |
| monocyte | CL:0000576 | 53.75 | gold quality |
| islet of Langerhans | UBERON:0000006 | 52.67 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 52.59 | gold quality |
| nucleus accumbens | UBERON:0001882 | 51.97 | gold quality |
| placenta | UBERON:0001987 | 51.83 | gold quality |
| caudate nucleus | UBERON:0001873 | 51.66 | gold quality |
| pancreas | UBERON:0001264 | 51.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.44 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- LINC02308 promotes the progression of glioma through activating mTOR/AKT-signaling pathway by targeting miR-30e-3p/TM4SF1 axis. (PMID:33945031)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.